Plant ID: NPO7539
Plant Latin Name: Raphanus sativus
Taxonomy Genus: Raphanus
Taxonomy Family: Brassicaceae
NCBI TaxonomyDB:
3726
Plant-of-the-World-Online:
n.a.
Anthelmintic; Antibacterial; Antifungal; Antiscorbutic; Antispasmodic; Appetizer; Astringent; Cancer; Carminative; Cholagogue; Digestive; Diuretic; Expectorant; Laxative; Poultice; Stomachic
Turkey; Israel; Italy; Lebanon; Philippines; Indonesia; India; China; Thailand; Jordan; South Korea
TSHR; | |
FFAR1; FFAR4; | |
TDP1; FAAH; MIF; TERT; HPGD; ALOX15; ALDH1A1; | |
EGFR; | |
CA2; CA1; CA12; CA9; CA14; CA7; CA5A; CA6; | |
PPARA; PPARD; PPARG; | |
NR1I2; | |
PTGS1; | |
TLR2; | |
LMNA; FABP3; FABP5; FABP2; FABP4; MAPT; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | FAAH | Anandamide amidohydrolase | O00519 | CHEMBL2243 |
Enzyme_unclassified | MIF | Macrophage migration inhibitory factor | P14174 | CHEMBL2085 |
Enzyme_unclassified | TERT | Telomerase reverse transcriptase | O14746 | CHEMBL2916 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 1 group C | PPARG | Peroxisome proliferator-activated receptor gamma | P37231 | CHEMBL235 |
Nuclear hormone receptor subfamily 1 group I | NR1I2 | Pregnane X receptor | O75469 | CHEMBL3401 |
Oxidoreductase | PTGS1 | Cyclooxygenase-1 | P23219 | CHEMBL221 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | EGFR | Epidermal growth factor receptor erbB1 | P00533 | CHEMBL203 |
Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.070E-13 | 4.658E-10 | CA1, CA12, CA2, CA5A, CA6, CA7, CA9 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 2.685E-08 | 2.784E-05 | CA1, CA12, CA2, CA5A, CA6, CA7, CA9, NR1I2, PPARA, PPARD, PPARG |
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 6.705E-08 | 5.615E-05 | FABP2, FABP3, FABP4, FABP5 |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 1.093E-06 | 5.806E-04 | NR1I2, PPARA, PPARD, PPARG |
MF | GO:0060089; molecular transducer activity | GO:0003707; steroid hormone receptor activity | 2.322E-06 | 1.053E-03 | NR1I2, PPARA, PPARD, PPARG |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 3.876E-06 | 1.623E-03 | FABP3, PPARA, PPARD, PPARG |
BP | GO:0050896; response to stimulus | GO:0042060; wound healing | 6.767E-06 | 2.585E-03 | ALOX15, EGFR, PPARA, PPARD |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 7.471E-06 | 2.757E-03 | CA2, CA7 |
BP | GO:0050896; response to stimulus | GO:0070542; response to fatty acid | 7.883E-06 | 2.861E-03 | FABP3, FFAR1, PPARG, TLR2 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 1.088E-05 | 3.687E-03 | CA2, CA9, EGFR, HPGD, TSHR |
BP | GO:0009987; cellular process | GO:0033554; cellular response to stress | 1.422E-05 | 4.489E-03 | ALOX15, CA2, CA9, EGFR, LMNA, MAPT, MIF, PPARD, PPARG, TDP1, TERT |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 2.485E-05 | 6.850E-03 | PPARA, PPARG |
BP | GO:0050896; response to stimulus | GO:0050728; negative regulation of inflammatory response | 3.313E-05 | 8.794E-03 | FFAR4, PPARA, PPARD, PPARG |
BP | GO:0009987; cellular process | GO:0050714; positive regulation of protein secretion | 3.352E-05 | 8.794E-03 | EGFR, FFAR1, MIF, PPARD, TLR2 |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 3.724E-05 | 9.112E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 3.724E-05 | 9.112E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 3.724E-05 | 9.112E-03 | ALOX15, HPGD |
MF | GO:0005488; binding | GO:0050543; icosatetraenoic acid binding | 3.724E-05 | 9.112E-03 | FABP3, PPARG |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 3.724E-05 | 9.112E-03 | CA1, CA2 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.050E-19 | 2.286E-15 | CA1, CA12, CA14, CA2, CA5A, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 2.804E-15 | 3.053E-11 | CA1, CA12, CA14, CA2, CA5A, CA6, CA7, CA9 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 2.997E-19 | 2.637E-17 | CA12, CA1, CA2, CA5A, CA7, CA6, CA9, CA14 |
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 1.048E-11 | 4.610E-10 | FABP2, FABP3, FABP4, FABP5, PPARG, PPARA, PPARD |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 8.841E-05 | 2.593E-03 | FABP4, TSHR, PTGS1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 4.149E-03 | 9.129E-02 | ALOX15, PTGS1 |
09160 Human Diseases | 09162 Immune diseases | hsa05320 | Autoimmune thyroid disease | 7.902E-02 | 2.266E-01 | TSHR |
09160 Human Diseases | 09161 Cancers | hsa05212 | Pancreatic cancer | 9.746E-02 | 2.266E-01 | EGFR |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 9.887E-02 | 2.266E-01 | EGFR |
09160 Human Diseases | 09161 Cancers | hsa05218 | Melanoma | 1.045E-01 | 2.266E-01 | EGFR |
09150 Organismal Systems | 09156 Nervous system | hsa04723 | Retrograde endocannabinoid signaling | 1.454E-01 | 2.266E-01 | FAAH |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 1.480E-01 | 2.266E-01 | EGFR |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | PPARD; FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 1 diabetes | E10 | PPARD; |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | FFAR1; |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | PPARD; |
E00-E89: Endocrine, nutritional and metabolic diseases | Metabolic disorders | E70-E89 | PPARD; |
K00-K95: Diseases of the digestive system | Non-alcoholic fatty liver disease | K76.0 | PPARD; |
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | PPARD; |
E00-E89: Endocrine, nutritional and metabolic diseases | Dyslipidaemias | E78 | PPARD; |
NA: NA | Dyslipidemia | NA | PPARD; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | PPARD; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Hyperlipidaemia | E78 | PPARD; |